[PDF][PDF] Acute coronary syndromes: morbidity, mortality, and pharmacoeconomic burden
DM Kolansky - American Journal of Managed Care, 2009 - ajmc.s3.amazonaws.com
Acute coronary syndromes (ACS), which include unstable angina and myocardial infarction
(MI) with or without ST-segment elevation, are life-threatening disorders that remain a …
(MI) with or without ST-segment elevation, are life-threatening disorders that remain a …
[HTML][HTML] Gender-related factors in medication adherence for metabolic and cardiovascular health
V Venditti, E Bleve, S Morano, T Filardi - Metabolites, 2023 - mdpi.com
This review explores the impact of gender on medication adherence in the context of
metabolic and cardiovascular diseases. Optimal adherence to medication is crucial for …
metabolic and cardiovascular diseases. Optimal adherence to medication is crucial for …
Association of temporal trends in risk factors and treatment uptake with coronary heart disease mortality, 1994-2005
HC Wijeysundera, M Machado, F Farahati, X Wang… - Jama, 2010 - jamanetwork.com
Context Coronary heart disease (CHD) mortality has declined substantially in Canada since
1994. Objective To determine what proportion of this decline was associated with temporal …
1994. Objective To determine what proportion of this decline was associated with temporal …
Resolving inequalities in care? Reduced mortality in the elderly after acute coronary syndromes. The Myocardial Ischaemia National Audit Project 2003–2010
CP Gale, BA Cattle, A Woolston, PD Baxter… - European heart …, 2012 - academic.oup.com
Aims To examine age-dependent in-hospital mortality for hospitalization with acute coronary
syndromes (ACS) in England and Wales. Methods and results Mixed-effects regression …
syndromes (ACS) in England and Wales. Methods and results Mixed-effects regression …
Extent of left ventricular scar predicts outcomes in ischemic cardiomyopathy patients with significantly reduced systolic function: a delayed hyperenhancement cardiac …
DH Kwon, CM Halley, TP Carrigan, V Zysek… - JACC: Cardiovascular …, 2009 - jacc.org
Objectives: The objective of the study was to determine whether the extent of left ventricular
scar, measured with delayed hyperenhancement cardiac magnetic resonance (DHE-CMR) …
scar, measured with delayed hyperenhancement cardiac magnetic resonance (DHE-CMR) …
Patterns and intensity of medical therapy in patients undergoing percutaneous coronary intervention
WB Borden, RF Redberg, AI Mushlin, D Dai… - Jama, 2011 - jamanetwork.com
Context The Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation
(COURAGE) study, which provided optimal medical therapy (OMT) to all patients and …
(COURAGE) study, which provided optimal medical therapy (OMT) to all patients and …
[HTML][HTML] Evidence-based pharmacotherapy after myocardial infarction in France: adherence-associated factors and relationship with 30-month mortality and …
BACKGROUND: International guidelines recommend long-term use of evidence-based
treatment (EBT) combining beta-blockers, aspirin/clopidogrel, statins and either angiotensin …
treatment (EBT) combining beta-blockers, aspirin/clopidogrel, statins and either angiotensin …
Trends in hospital treatments, including revascularisation, following acute myocardial infarction, 2003–2010: a multilevel and relative survival analysis for the National …
Objective To investigate temporal changes in survival after acute myocardial infarction (AMI)
by early invasive strategy. Methods Accelerated failure time and 6-month relative survival …
by early invasive strategy. Methods Accelerated failure time and 6-month relative survival …
Management and Two-Year Long-Term Clinical Outcome of Acute Coronary Syndrome in Japan–Prevention of AtherothrombotiC Incidents Following Ischemic …
H Daida, K Miyauchi, H Ogawa, H Yokoi… - Circulation …, 2013 - jstage.jst.go.jp
Background: Japanese patients have been at low risk for cardiovascular events compared
with Western countries, but the data regarding current treatment status and rate of …
with Western countries, but the data regarding current treatment status and rate of …
Use of secondary prevention drug therapy in patients with acute coronary syndrome after hospital discharge
HY Lee, CE Cooke, TA Robertson - Journal of Managed Care Pharmacy, 2008 - jmcp.org
BACKGROUND: Acute coronary syndrome includes life-threatening clinical conditions
ranging from unstable angina to non-Q-wave myocardial infarction and Q-wave myocardial …
ranging from unstable angina to non-Q-wave myocardial infarction and Q-wave myocardial …